(Q37969596)

26 August 2017

title

Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium (English)

1 reference

26 August 2017

0 references

1 reference

2

Peter Malfertheiner

1 reference

26 August 2017

Christoph A Jacobi

1

1 reference

26 August 2017

publication date

12 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

29

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

600-607

1 reference

Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions

26 August 2017

cites work

1 reference

Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917

21 January 2018

1 reference

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

21 January 2018

1 reference

The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens

21 January 2018

1 reference

Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

21 January 2018

1 reference

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling

21 January 2018

1 reference

NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

21 January 2018

1 reference

Defensins and inflammation: the role of defensins in inflammatory bowel disease

21 January 2018

1 reference

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells

21 January 2018

1 reference

The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in e

21 January 2018

1 reference

Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria

21 January 2018

1 reference

The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1

21 January 2018

1 reference

The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.

21 January 2018

1 reference

Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair

21 January 2018

1 reference

The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.

21 January 2018

1 reference

Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation

21 January 2018

1 reference

Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.

21 January 2018

1 reference

E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells

21 January 2018

1 reference

Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway

21 January 2018

1 reference

Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.

21 January 2018

1 reference

A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.

21 January 2018

1 reference

Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide

21 January 2018

1 reference

Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

21 January 2018

1 reference

Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice.

21 January 2018

1 reference

Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.

21 January 2018

1 reference

Clinical use of E. coli Nissle 1917 in inflammatory bowel disease

21 January 2018

1 reference

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study

21 January 2018

1 reference

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

21 January 2018

1 reference

Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities

21 January 2018

1 reference

The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.

21 January 2018

1 reference

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

21 January 2018

1 reference

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

21 January 2018

1 reference

Are probiotics detectable in human feces after oral uptake by healthy volunteers?

21 January 2018

1 reference

Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host

21 January 2018

1 reference

Specific Proliferative and Antibody Responses of Premature Infants to Intestinal Colonization with Nonpathogenic Probiotic E. coli Strain Nissle 1917

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000333307

1 reference

26 August 2017

1 reference